1706P Efficacy, safety and PKPD of 23ME-00610, a first-in-class anti-CD200R1 antibody, in patients with advanced or metastatic clear-cell renal cell carcinoma (ccRCC): Results from a multi-center multi-country phase I/IIa expansion cohort
| Autor: | Krystal, J., Khaki, A.R., Spira, A.I., Abdul Razak, A.R., Maslyar, D., Glatt, D.M., Hwang, C.C., Diep, A.N., Schmidt, M., Vold, R. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S1023-S1023 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|